COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 366: Articles 3651-3660  | Next

Establishing thresholds for cytokine storm and defining their relationship to disease severity in respiratory viral infections
Souquette, A., Crawford, J. C., Wolf, J., Blair, A., Agrawal, M., Boywid, L., McNair, K., Hysmith, N. D., Hundman, C., Bahadoran, A., Arnold, S. R., SJTRC Study Team, , Smallwood, H., Green, A., Thomas, P. G.
10.1101/2023.07.06.548022 — Posted: 2023-07-07
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Carrillo, J., Avila-Nieto, C., Vergara-Alert, J., Amengual-Rigo, P., Ainsua-Enrich, E., Brustolin, M., Rodriguez de la Concepcion, M. L., Pedreno-Lopez, N., Rodon, J., Urrea, V., Pradenas, E., Marfil, S., Ballana, E., Riveira-Munoz, E., Perez, M., Roca, N., Tarres-Freixas, F., Carabelli, J., Cantero, G., Pons-Grifols, A., Rovirosa, C., Aguilar-Gurrieri, C., Ortiz, R., Barajas, A., Trinite, B., Lepore, R., Munoz-Basagoiti, J., Perez-Zsolt, D., Izquierdo-Useros, N., Valencia, A., Blanco, J., Clotet, B., Guallar, V., Segales, J.
10.1101/2023.07.07.548077 — Posted: 2023-07-07
Single cell susceptibility to SARS-CoV-2 infection is driven by variable cell states
Reffsin, S., Miller, J., Ayyanathan, K., Dunagin, M. C., Jain, N., Schultz, D. C., Cherry, S., Raj, A.
10.1101/2023.07.06.547955 — Posted: 2023-07-07
In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses
Lim, T., Rajoriya, S., Kim, B., Prayitno, S. p., Natasha, A., Park, J., Jang, N. Y., Im, H., Shim, H. S., Yoo, J., Kim, J. W., Lee, E.-W., Shin, H. J., Kim, S. H., Kim, W.-K.
10.1101/2023.07.06.547945 — Posted: 2023-07-07
SARS-CoV-2 Nsp1 regulates translation start site fidelity to promote infection
Aviner, R., Lidsky, P. V., Xiao, Y., Tasseto, M., Zhang, L., McAlpine, P. L., Elias, J., Frydman, J., Andino, R.
10.1101/2023.07.05.547902 — Posted: 2023-07-07
DECLINE OF HANDWASHING AND MASKING AMONG THE GENERAL POPULATION IN POST COVID-19 PANDEMIC: INSIGHTS FROM A MIXED METHODS STUDY IN GHANA
Lamptey, E., Yaidoo, S., tia Banoya, M., osei Boakye, E., Aki Benita, D., Kumi Senkyire, E.
10.1101/2023.07.03.23292119 — Posted: 2023-07-06
The K+/Na+ innate immune system is involved in the susceptibility to and severity of COVID-19: a systematic review and retrospective cohort study
Li, C., Luo, Y., Li, Y., Dai, J.
10.1101/2023.07.03.23292126 — Posted: 2023-07-06
Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial
Bennett, C., Rivers, E. J., Woo, W., Bloch, M., Cheung, K., Griffin, P., Mohan, R., Deshmukh, S., Arya, M., Cumming, O., Neville, A. M., Pardey, T. M., Plested, J. S., Cloney-Clark, S., Zhu, M., Kalkeri, R., Patel, N., Buchanan, A., Marcheschi, A., Swan, J., Smith, G., Cho, I., Glenn, G. M., Walker, R., Mallory, R.
10.1101/2023.07.05.23291954 — Posted: 2023-07-06
Intracardiac Thrombus in COVID-19 Inpatients: A Nationwide Study of Incidence, Predictors and Outcomes
Agrawal, A., Bajaj, S., Bhagat, U., Chandna, S., Arockiam, A. D., Chan, N., Haroun, E., Gupta, R., Badwan, O., Shekhar, S., Kathavarayan Ramu, S., Nayar, D., Jaber, W. A., Griffin, B. P., Wang, T. K. M.
10.1101/2023.07.05.23292278 — Posted: 2023-07-06
The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination
Hsieh, H.-C., Chen, C.-C., Chou, P.-H., Liu, W.-C., Wu, S.-C.
10.1101/2023.07.05.547781 — Posted: 2023-07-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).